|
| 37963289 | Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET. | Alzheimers Dement | 2024 |
| 35989502 | Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population. | Hepatology | 2023 |
| 35642504 | Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD. | Hepatology | 2023 |
| 37248223 | Evidence against a temporal association between cerebrovascular disease and Alzheimer's disease imaging biomarkers. | Nat Commun | 2023 |
| 37080558 | Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH. | Hepatology | 2023 |
| 36789483 | Predicting amyloid PET and tau PET stages with plasma biomarkers. | Brain | 2023 |
| 36940423 | CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation. | Am J Gastroenterol | 2023 |
| 34265444 | Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study. | Clin Gastroenterol Hepatol | 2022 |
| 35843374 | Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design. | J Hepatol | 2022 |
| 35764037 | CSF phosphorylated tau as an indicator of subsequent tau accumulation. | Neurobiol Aging | 2022 |
| 36003089 | The Utility of Multistate Models: A Flexible Framework for Time-to-Event Data. | Curr Epidemiol Rep | 2022 |
| 35227234 | Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation. | BMC Cancer | 2022 |
| 35181550 | Response to "On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021". | Neuroimage | 2022 |
| 35310829 | Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk. | Brain Commun | 2022 |
| 35086822 | Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 34432123 | Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis. | Eur Radiol | 2022 |
| 33010409 | Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD. | Clin Gastroenterol Hepatol | 2021 |
| 33617474 | Distribution and Incidence of Blood-Borne Infection among Blood Donors from Regional Transfusion Centers in Burkina Faso: A Comprehensive Study. | Am J Trop Med Hyg | 2021 |
| 33638343 | Using machine learning to improve the accuracy of patient deterioration predictions: Mayo Clinic Early Warning Score (MC-EWS). | J Am Med Inform Assoc | 2021 |
| 33586159 | Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis. | J Magn Reson Imaging | 2021 |
| 33772866 | NIA-AA Alzheimer's Disease Framework: Clinical Characterization of Stages. | Ann Neurol | 2021 |
| 34103314 | Longitudinal cohorts for harnessing the electronic health record for disease prediction in a US population. | BMJ Open | 2021 |
| 34118395 | Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation. | Neuroimage | 2021 |
| 34333107 | Relationships between β-amyloid and tau in an elderly population: An accelerated failure time model. | Neuroimage | 2021 |
| 33074304 | Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment. | JAMA Neurol | 2021 |
| 33043497 | Analysis of time-to-event for observational studies: Guidance to the use of intensity models. | Stat Med | 2021 |
| 33035667 | Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers. | Neuroimage | 2021 |
| 33023823 | BALAD and BALAD-2 predict survival of hepatocellular carcinoma patients: a North American cohort study. | HPB (Oxford) | 2021 |
| 30582669 | The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery. | Hepatology | 2020 |
| 31926330 | Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation. | Clin Immunol | 2020 |
| 32018185 | Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes. | J Neurol Sci | 2020 |
| 32063031 | Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations. | Clin Trials | 2020 |
| 33094327 | Predicting future rates of tau accumulation on PET. | Brain | 2020 |
| 32740886 | Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib. | Hepatol Int | 2020 |
| 32119126 | Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma. | Hepatology | 2020 |
| 32179748 | The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias. | Blood Cancer J | 2020 |
| 32172321 | The impact of arm lymphedema on healthcare utilization during long-term breast cancer survivorship: a population-based cohort study. | J Cancer Surviv | 2020 |
| 30611450 | Large Chromosomal Rearrangements Yield Biomarkers to Distinguish Low-Risk From Intermediate- and High-Risk Prostate Cancer. | Mayo Clin Proc | 2019 |
| 31644852 | Identification of Anonymous MRI Research Participants with Face-Recognition Software. | N Engl J Med | 2019 |
| 32025604 | Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery. | Hepatol Commun | 2019 |
| 31501889 | The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes. | Brain | 2019 |
| 31470068 | The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study. | J Hepatol | 2019 |
| 31211344 | Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia. | JAMA | 2019 |
| 31435771 | Cognitive function and neuropathological outcomes: a forward-looking approach. | J Neurol | 2019 |
| 31577570 | Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study. | Am J Gastroenterol | 2019 |
| 31305929 | Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework. | JAMA Neurol | 2019 |
| 31476655 | Automatic extraction and assessment of lifestyle exposures for Alzheimer's disease using natural language processing. | Int J Med Inform | 2019 |
| 31101803 | Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies. | Blood Cancer J | 2019 |
| 30713046 | Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015. | Mayo Clin Proc | 2019 |
| 31147421 | Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults. | Neurology | 2019 |